Tower Research Capital LLC (Trc) Opiant Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$9.38 - $20.29 $2,907 - $6,289	310 Added 71.43%	744 $15,000
Q3 2022 Nov 10, 2022	SELL	$9.52 - $13.48 $8,901 - $12,603	-935 Reduced 68.3%	434 $4,000
Q2 2022 Aug 15, 2022	BUY	$10.12 - $23.32 $12,295 - $28,333	1,215 Added 788.96%	1,369 $16,000
Q1 2022 May 12, 2022	BUY	$19.54 - $33.59 $3,009 - $5,172	154 New	154 $3,000
Q4 2021 Feb 14, 2022	SELL	$22.51 - $36.79 $3,106 - $5,077	-138 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.28 - $25.79 $1,593 - $3,094	-120 Reduced 46.51%	138 $4,000
Q2 2021 Aug 16, 2021	SELL	$10.5 - $14.19 $262 - $354	-25 Reduced 8.83%	258 $3,000
Q1 2021 May 17, 2021	SELL	$8.2 - $14.49 $5,190 - $9,172	-633 Reduced 69.1%	283 $3,000
Q4 2020 Feb 16, 2021	BUY	$6.87 - $8.88 $4,101 - $5,301	597 Added 187.15%	916 $7,000
Q3 2020 Nov 16, 2020	SELL	$7.48 - $9.54 $25,491 - $32,512	-3,408 Reduced 91.44%	319 $3,000
Q2 2020 Aug 13, 2020	BUY	$8.64 - $11.87 $32,201 - $44,239	3,727 New	3,727 $34,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.